- The Deep Tech Newsletter
- Posts
- DTN 113: The Rare Earth Cold War
DTN 113: The Rare Earth Cold War
Plus: The organ-on-a-chip boom, first flight of a detonation rocket engine, breakthrough personalized CRISPR therapy, and more.

“The beauty of industrial investments is that they touch things people think are difficult. As such, they're much more defensible, especially in the age of agentic AI systems further lowering the barrier to the production of purely digital goods and services.”

“The future of everything from smartphones, to military equipment, to electric vehicles hangs on 17 rare earth minerals and the magnets that they’re made into. And China, the world’s largest refiner and producer, is tightening its grip and threatening the US’ largest automakers.
Over the last 30 years, China has methodically cornered the market on mining and refining rare earth minerals, which are used to produce a variety of common items like passenger vehicles and everyday electronics. In the wake of US President Donald Trump’s increasingly aggressive trade war, China is leveraging its position as the world’s largest producer, at the expense of the American auto industry.”

China launches first of 2,800 satellites for AI space computing constellation
FDA shift from animal testing fuels organoid, organ-on-chip demand
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Space Force testing space-based sensors to track airborne targets
GM's new battery tech could be a breakthrough for affordable EVs
Britain is now the biggest funder of solar-geoengineering research
Venus Aerospace flies its rotating detonation rocket engine for the first time
Nuclear waste could power Europe for decades. This startup plans to prove it
‘Supersonic’ planes could make a comeback in the U.S. after decades-long ban
Gene-editing therapy made in just 6 months helps baby with life-threatening disease
Cognichip emerges from stealth with the goal of using generative AI to develop new chips
Fieldstone Bio is building microbes that can sense everything from TNT to arsenic
Why the world keeps getting shocked by China’s technological progress
A decade-long search for a battery that can end the gasoline era
Google inks deal to develop 1.8 GW of advanced nuclear power
Vertical Aerospace has a plan to capitalize on Europe’s defense tech moment


KJ Muldoon, a baby treated with a personalized gene-editing drug, relaxes with his parents and siblings.
Doctors at the Children’s Hospital of Philadelphia have successfully treated a baby, KJ Muldoon, with the world’s first personalized gene-editing drug designed to correct a deadly metabolic disorder caused by a single DNA mutation. The experimental therapy, developed in just seven months, used a cutting-edge technique called base editing to precisely rewrite a single DNA letter. The case highlights both the transformative potential of personalized gene editing and the challenges of making such treatments scalable and economically viable. (via MIT Technology Review)

Research brings us a step closer to synthetic sugars as medicine
With AI, researchers predict the location of virtually any protein within a human cell
Spin-based memory advance brings brain-like computing closer to reality
Photonic chip design offers simpler solution for one-way light flow in optical circuits
Nanoplastics generated from real-world plastic waste readily adsorb heavy metal ions, study reveals
Real-world evidence couples genomic biomarkers with therapeutic outcomes for canine hemangiosarcoma

Zeno Power raises $50M Series B to begin producing nuclear batteries
Reflect Orbital raises $20M Series A to ramp up development of its sun-reflecting sat constellation
Chipiron building ultra-low portable MRI scanner following $17M
Dutch biotech Azafaros gains €132M series B to fund phase 3 trials of brain-penetrant drug
Sirius bags $50M series B2 for cardiovascular siRNA pipeline
Therini Bio raises $39M to launch Alzheimer’s and DME trials
Pathos AI secures $365M series D to fund trial of Novo Nordisk solid tumor drug
PhaseV raises $50M for AI platform to enhance clinical trials
Life Sciences provider Tobin Scientific raises $65M in funding
Trump crypto advisor raises $710M for Bitcoin investing firm
Realta Fusion taps $36M in fresh funds for its fusion-in-a-bottle reactor
Pluto Bio raises $3.6M in funding for its AI-powered platform for computation biology
Diagnotics company CND Life Sciences raises $13.5M in Series A3
Breathe Battery Technologies raises $21M in Series B funding
Saildrone, a Danish startup specializing in maritime autonomy, raised a $60M funding round

What the hell are rare earth elements? / Why alien languages could be far stranger than we imagine Essays / E-COM: The $40M USPS project to send email on paper / Robot chefs take over at South Korea's highway restaurants, to mixed reviews / Harvard Law Paid $27 for a Copy of Magna Carta. It's an Original / An Under-Appreciated Threat from Airborne Attacks on Large Nuclear Power Plants / About as close to aliens as we’ll ever get.’ Can AI crack animal language? / French crypto sector in shock after wave of violent attacks / Beyond qubits: Meet the qutrit (and ququart) / Scientists in Mexico develop tortilla for people with no fridge / Residents of California town baffled by mysterious exploding birds / Seagrass bread as a food product of the future / How Did Geometry Create Modern Physics? / Indian police are trying to ‘read minds' of suspects, over neuroscientists' objections / Large Hadron Collider Physicists Turn Lead into Gold—For a Fraction of a Second / Your fingers wrinkle in the same pattern every time you're in the water for too long, study shows / Gabon longs to cash in on sacred hallucinogenic remedy / Universe expected to decay in 10⁷⁸ years, much sooner than previously thought / Elizabeth Holmes’ partner reportedly fundraising for new blood-testing startup / Could this be the end of menopause as we know it? / Why alien languages could be far stranger than we imagine